Tripedia – Diphtheria, Tetanus Toxoid, and Acellular Pertussis Vaccine (DTaP)

[08 April 2011]

Products Affected - Description

Tripedia Vaccine, Sanofi Pasteur
0.5 mL single-dose vial, package of 10 (NDC 49281-0298-10) – discontinued

Reason for the Shortage

Sanofi Pasteur discontinued Tripedia in 2011. The company will continue to distribute the vaccine until supplies are depleted.

Estimated Resupply Dates

Sanofi Pasteur discontinued Tripedia vaccine. Tripedia (NDC 49281-0298-10) is still currently available; however, depletion of supplies is estimated to occur in the 2nd quarter of 2011.

Alternative Agents & Management

  • DTaP and Tdap vaccines both contain diphtheria, tetanus toxoid, and acellular pertussis. DTaP vaccines (eg, Tripedia, Daptacel, and Infanrix) are recommended for use in infants and children under 7 years of age. Tdap vaccines (eg, Adacel, Boostrix) are recommended for use in adolescents and adults 10 to 64 years of age.
  • Sanofi Pasteur has available Daptacel DTaP vaccine in single-dose vials (NDC 49281-0286-10).
  • GSK has available Infanrix DTaP vaccine in single-dose vials (NDC 58160-0810-11) and syringes (NDC 58160-0810-52).

Related Shortages


April 8, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
ASHP Product Listing